DELETE Diagnosis, Medication Selection, and Dosing for Specific Indications

Recently published articles about DELETE Diagnosis, Medication Selection, and Dosing for Specific Indications

DELETE Diagnosis, Medication Selection, and Dosing for Specific Indications

Guideline 2: Delirium

January 1, 2004

DELETE Diagnosis, Medication Selection, and Dosing for Specific Indications

Guideline 5: Delusional Disorder

January 1, 2004

DELETE Diagnosis, Medication Selection, and Dosing for Specific Indications

Guideline 3: Dementia

January 1, 2004

DELETE Diagnosis, Medication Selection, and Dosing for Specific Indications

Guideline 10: Generalized Anxiety Disorder

January 1, 2004

DELETE Diagnosis, Medication Selection, and Dosing for Specific Indications

Guideline 11: Hypochondriasis

January 1, 2004

DELETE Diagnosis, Medication Selection, and Dosing for Specific Indications

Guideline 8: Mania (Bipolar I Disorder)

January 1, 2004

Recent JCP Articles on DELETE Diagnosis, Medication Selection, and Dosing for Specific Indications

SSRI Discontinuation and AUD Relapse

Case Report

SSRI Discontinuation and AUD Relapse

August 26, 2024

A man with AUD achieves sobriety on treatment with an SSRI and naltrexone, but then stops taking the SSRI to participate in a psilocybin “ceremony.” What factors contributed to...

Mark A. Frye, Balwinder Singh, Scott A. Breitinger, et al

Reproductive Pharmacovigilance and Best Practices

Commentary

Reproductive Pharmacovigilance and Best Practices

August 26, 2024

Dr Freeman discusses a recent study by Pacilio et al that characterized real world practices around ketamine treatment and pregnancy testing, consent processes, and contraception use. She emphasizes the...

Marlene P. Freeman

Olanzapine and Mirtazapine for Cancer-Related Anorexia

Clinical and Practical Psychopharmacology

Olanzapine and Mirtazapine for Cancer-Related Anorexia

August 21, 2024

Dr Andrade discusses two RCTs that investigated the utility of olanzapine and mirtazapine in addressing appetite loss in cancer patients.

Chittaranjan Andrade

Recent PCC Articles on DELETE Diagnosis, Medication Selection, and Dosing for Specific Indications

Panic Attacks Masquerading as Intractable Vomiting

Case Report

Panic Attacks Masquerading as Intractable Vomiting

August 22, 2024

The authors present a perplexing and atypical manifestation of panic attacks presenting as intractable vomiting in a young patient.

Ajzal A. Zain, Tanvi Mittal, Nishanth Jalaja Haridas

Smartphone Applications: Therapy at Your Fingertips

Letter to the Editor

Smartphone Applications: Therapy at Your Fingertips

August 20, 2024

The authors discuss the advancements in smartphone applications for psychiatry, as well as some of the risks.

Vania Modesto-Lowe, Sofia Adams, Amanda Rossi

Zeroing in on Xylazine

Letter to the Editor

Zeroing in on Xylazine

August 15, 2024

The authors discuss the need to raise awareness among US public and health care professionals about xylazine due to its infiltration into the illicit drug supply.

Jasleen Kaur, Megan Nosol, Vania Modesto-Lowe

Featured DELETE Diagnosis, Medication Selection, and Dosing for Specific Indications Research

Scientists Find Environmental Plastics in Human Brains

news

Scientists Find Environmental Plastics in Human Brains

August 23, 2024

Research reveals that plastics are accumulating in human brains, with concentrations in the frontal cortex rising by more than 50%.

Weekly Mind Reader: When is Vomiting Not a Gut Problem?

news

Weekly Mind Reader: When is Vomiting Not a Gut Problem?

August 23, 2024

This week features a report on chronic vomiting, a review of the economic impact of cognitive impairment, and how apps can advance care.

University Develops AI-Powered Brain Implant for Parkinson’s Patients

news

University Develops AI-Powered Brain Implant for Parkinson’s Patients

August 22, 2024

Researchers developed an AI-driven brain implant that offers 24-hour treatment for Parkinson's, improving movement and sleep symptoms.